The Medicines Co (MDCO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

8 SYLVAN WAY PARSIPPANY, NJ 07054

Operates as a pharmaceutical company that specializes in acute care hospital products. Its first acute care hospital product, Angiomax (bivalirudin), is a direct thrombin inhibitor used as an anticoagulant in patients undergoing coronary angioplasty.

Data based on most recent fiscal year report
Market Cap2.341 Billion Shares Outstanding72.9 Million Avg Volume2.254 Million
1-Yr BETA vs S&P TR1.255 Current Ratio3.21 Quick Ratio3.18
View SEC Filings from MDCO instead.
Q2 2019 All Institutions Hedge Funds 1
To trade MDCO now:
Filers who had this stock in their top 10: 7 10 (1.03%)
13F Filers holding this stock: 225 42 (4.34%)
Aggregate 13F shares on 06/30/2019: 102.434 Million 22.663 Million
Aggregate 13F shares on 03/31/2019: 99.662 Million 21.061 Million
Percent change: 2.78% 7.61%
Funds creating new positions: 51 17
Funds Adding to an existing position: 90 13
Funds closing out their position: 25 8
Funds reducing their position: 57 12
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MDCO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MEANWELL CLIVE CHIEF INNOVATION OFFICER

  • Officer
  • Director
290,810 2019-08-30 4

RODIN STEPHEN M EVP AND GENERAL COUNSEL

  • Officer
28,630 2019-08-30 4

TIMNEY MARK CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
30,280 2019-08-30 4

WIJNGAARD PETER CHIEF DEVELOPMENT OFFICER

  • Officer
2,448 2019-08-30 3

ESHELMAN FREDRIC N

  • Director
1,604,584 2019-08-16 0

DENNER ALEXANDER J

  • Director
4,216,092 2019-06-28 9

SBLENDORIO GLENN

  • Director
28,078 2019-06-27 0

KELLEY JOHN P

  • Director
0 2019-06-19 0

GERMANO GENO J

0 2019-06-05 1

KELLY JOHN C.

  • Director
32,148 2019-05-30 1

PANAYIOTOPOULOS PARIS

  • Director
13,881 2019-05-30 1

SCHLESINGER SARAH J.

  • Director
7,429 2019-05-30 1

SAVAGE ROBERT G.

199,869 2019-05-14 0

HUGIN ROBERT J

  • Director
5,285 2019-04-30 0

COX CHRISTOPHER T EVP & CHIEF CORP. DEV. OFFICER

  • Officer
392,942 2019-03-04 4

VISIOLI CHRISTOPHER CHIEF FINANCIAL OFFICER

  • Officer
7,252 2019-03-04 2

SPIGELMAN MELVIN K

  • Director
48,305 2018-08-15 0

KINGSLEY STUART A

  • Director
0 2018-06-08 0

KESSLER ARMIN M

  • Director
138,493 2018-05-10 0

WYATT ELIZABETH H S

  • Director
60,633 2018-03-22 0

CROUSE WILLIAM

  • Director
53,133 2018-03-21 0

O'CONNOR WILLIAM BERNARD CHIEF FINANCIAL OFFICER

  • Officer
21,882 2018-03-02 0

FRAZIER JEFF EVP, CHIEF HUMAN STRATEGY

  • Officer
34,350 2018-03-02 0

FURSE BRENT

0 2018-01-05 0

SHIGETA HIROAKI

  • Director
26,784 2017-05-25 0

KUSIAK VICTORIA EVP, CHIEF INTEGRITY OFFICER

  • Officer
3,519 2014-03-03 0

HEIMAN CORNELIS EVP, CHIEF INNOVATION OFFICER

  • Officer
11,457 2014-03-03 0

ANTINORI PAUL MICHAEL SR. VP & GENERAL COUNSEL

  • Officer
No longer subject to file 2014-02-25 0

ROHRBACKER LESLIE C VP, CHIEF HUMAN STRATEGY OFFIC

  • Officer
13,628 2012-02-21 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD PARTNERS, LP

DEERFIELD MANAGEMENT CO /NY

DEERFIELD INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
No longer subject to file 2011-04-04 0

JOHNSON T SCOTT

  • Director
No longer subject to file 2009-07-21 0

WATSON PACICCO KELLI SENIOR VICE PRESIDENT

  • Officer
2,211 2009-02-20 0

NEWBERRY CATHARINE S SENIOR VICE PRESIDENT

  • Officer
No longer subject to file 2009-01-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WIJNGAARD PETER - Officer CHIEF DEVELOPMENT OFFICER

2019-08-30 A 491 $21.60 a 2,448 2,448.00 direct

RODIN STEPHEN M - Officer EVP AND GENERAL COUNSEL

2019-08-30 A 491 $21.60 a 28,630 28,630.00 direct

MEANWELL CLIVE - Director - Officer CHIEF INNOVATION OFFICER

2019-08-30 A 491 $21.60 a 290,810 290,810.00 direct

TIMNEY MARK - Director - Officer CHIEF EXECUTIVE OFFICER

2019-08-30 A 491 $21.60 a 30,280 30,280.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments